CAPRICOR INC has a total of 26 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are NANJING KEYGEN BIOTECH CO LTD, HUAIAN KANGYILAI STEM CELL BIOTECHNOLOGY CO LTD and ADVANCED REGEN MEDICAL TECH LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Australia | 2 | |
#5 | Canada | 1 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Rodriguez-Borlado Luis | 14 |
#2 | Smith Rachel | 11 |
#3 | Kreke Michelle | 11 |
#4 | Marban Linda | 10 |
#5 | Hemmati Houman | 9 |
#6 | Peck Kiel A | 8 |
#7 | Moseley Jennifer J | 6 |
#8 | Ibrahim Ahmed | 6 |
#9 | Peck Kiel | 5 |
#10 | Hanscome Peter | 4 |
Publication | Filing date | Title |
---|---|---|
AU2019216224A1 | Activation-induced tissue-effector cells suitable for cell therapy and extracelluar vesicles derived therefrom | |
WO2018204889A1 | Methods of treating systemic graft-versus-host disease with extracellular vesicles | |
US2019099370A1 | Method of preventing or treating radiation-induced dermatitis with extracellular vesicles | |
EP3429557A1 | Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles | |
EP3226875A1 | Processes for producing stable exosome formulations | |
WO2013184527A1 | Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy | |
WO2010118059A1 | Systems and methods for cardiac tissue repair |